2012-01-30 00:00:00,Baxter International Announces FDA Approval Of Expanded Indication For TISSEEL For General Hemostasis In Surgery
2012-09-04 00:00:00,Baxter International Inc Submits Application For FDA Approval Of Recombinant Factor IX for Treatment Of Hemophilia B
